Velesco Pharma, an early stage pharmaceutical development and clinical manufacturing company, has boosted its cGMP analytical testing capabilities with an expansion of its analytical laboratory in Plymouth, Mich. The addition of a new cGMP analytical testing laboratory increases the breadth of services to more fully meet the needs of its broad client base.
The main activity supported in the new cGMP-compliant laboratory is the testing of clients’ stability samples. Specific testing activity includes:
In addition to executing clients’ cGMP stability programs, the laboratory is ideal for the testing of samples for cleaning validation studies, in vitro equivalency determination and test article characterization.
“Our new cGMP analytical laboratory is impressively designed, equipped and staffed so that we can meet our clients’ growing demand for analytical services,” said Dave Barnes, Ph.D., chief executive officer at Velesco. “We look forward to collaborating with our clients to ensure strong cGMP testing programs. Our clients can be confident their testing will exceed FDA compliance requirements.”
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.